We are live on ! Find out more
EAM

Exane Asset Management Portfolio holdings

AUM $277M
1-Year Est. Return 26.27%
This Fund
S&P 500
This Quarter Est. Return
-1.3%
1 Year Est. Return
+26.27%
3 Year Est. Return
+77.5%
5 Year Est. Return
+80.92%
10 Year Est. Return
+419.8%
AUM
$258M
AUM Growth
+$65.7M
Cap. Flow
+$68M
Cap. Flow %
26.4%
Top 10 Hldgs %
62.2%
Holding
40
New
15
Increased
9
Reduced
8
Closed
8

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$20.1M
2
GILD icon
Gilead Sciences
GILD
+$16.9M
3
QGENF
QIAGEN NV
QGENF
+$14.3M
4
PPG icon
PPG Industries
PPG
+$12.9M
5
APD icon
Air Products & Chemicals
APD
+$12.4M

Top Sells

Rank Stock Value
1
TMUS icon
T-Mobile US
TMUS
+$40.9M
2
CELG
Celgene Corp
CELG
+$10.3M
3
MON
Monsanto Co
MON
+$8.56M
4
WLK icon
Westlake Corp
WLK
+$7.45M
5
SHW icon
Sherwin-Williams
SHW
+$6.67M

Sector Composition

Rank Sector Weight
1 Healthcare 37.4%
2 Materials 17.75%
3 Communication Services 12.17%
4 Financials 11.68%
5 Industrials 5.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SHPG
1
DELISTED
Shire pic
SHPG
$25.1M 9.73%
136,214
+61,458
+82% +$11.1M
AGN
2
DELISTED
Allergan plc
AGN
$19.8M 7.69%
85,815
+39,892
+87% +$9.2M
TIMB icon
3
TIM SA
TIMB
$10.6B
$18.4M 7.13%
1,742,102
-152,604
-8% -$1.56M
ALXN
4
DELISTED
Alexion Pharmaceuticals
ALXN
$16.5M 6.41%
+141,454
New +$20.1M
GILD icon
5
Gilead Sciences
GILD
$165B
$15.9M 6.18%
190,955
+190,782
+110,279% +$16.9M
QGENF
6
DELISTED
QIAGEN NV
QGENF
$14.3M 5.53%
+642,752
New +$14.3M
CNH
7
CNH Industrial
CNH
$12.8B
$13.1M 5.08%
2,038,979
+186,390
+10% +$1.15M
BMRN icon
8
BioMarin Pharmaceuticals
BMRN
$11.4B
$12.7M 4.93%
163,222
+17,402
+12% +$1.48M
APD icon
9
Air Products & Chemicals
APD
$66.1B
$12.3M 4.76%
+93,395
New +$12.4M
PPG icon
10
PPG Industries
PPG
$25.8B
$12.3M 4.76%
+117,746
New +$12.9M
C icon
11
Citigroup
C
$216B
$10.5M 4.07%
247,681
+16,833
+7% +$744K
ECL icon
12
Ecolab
ECL
$75.6B
$9.14M 3.55%
+77,080
New +$8.99M
ASH icon
13
Ashland
ASH
$3.1B
$8.94M 3.47%
+159,154
New +$8.81M
BAC icon
14
Bank of America
BAC
$424B
$8.72M 3.38%
+656,844
New +$9.23M
UBS icon
15
UBS Group
UBS
$169B
$8.24M 3.2%
+628,317
New +$9.6M
TMUS icon
16
T-Mobile US
TMUS
$212B
$6.75M 2.62%
156,000
-996,500
-86% -$40.9M
CRTO icon
17
Criteo
CRTO
$1.11B
$6.24M 2.42%
+135,808
New +$5.85M
GCP
18
DELISTED
GCP Applied Technologies Inc.
GCP
$6.15M 2.38%
235,986
-19,473
-8% -$457K
GRA
19
DELISTED
W.R. Grace & Co.
GRA
$5.78M 2.24%
78,957
-46,086
-37% -$3.52M
APTV icon
20
Aptiv
APTV
$12.1B
$5.68M 2.2%
90,657
+29,673
+49% +$2.07M
DBVT
21
DBV Technologies
DBVT
$857M
$4.41M 1.71%
+13,509
New +$4.38M
VMC icon
22
Vulcan Materials
VMC
$36.4B
$3.13M 1.21%
26,000
+10,500
+68% +$1.19M
GS icon
23
Goldman Sachs
GS
$311B
$2.64M 1.03%
17,783
-28,314
-61% -$4.42M
CVX icon
24
Chevron
CVX
$378B
$2.3M 0.89%
21,933
+4,359
+25% +$438K
APC
25
DELISTED
Anadarko Petroleum
APC
$2.26M 0.88%
+42,477
New +$2.15M
1
2

Similar funds

RCA
Ranch Capital Advisors Sarasota, Florida $277M AUM 22.08% 1-Year Est. Return
TAM
Townsend Asset Management Raleigh, North Carolina $277M AUM 16.26% 1-Year Est. Return
IIA
ICW Investment Advisors Scottsdale, Arizona $277M AUM 12.1% 1-Year Est. Return
TAP
Tounjian Advisory Partners Fort Myers, Florida $277M AUM 21.37% 1-Year Est. Return
TLA
Tanglewood Legacy Advisors Houston, Texas $276M AUM 16.97% 1-Year Est. Return
1NWS
1 North Wealth Services Annapolis, Maryland $277M AUM 15.28% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

Exane Asset Management's Q2 2016 Portfolio in Review

As of Q2 2016, Exane Asset Management held 40 positions worth $258M, up 34% from $192M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Exane Asset Management deployed $68M of net new capital in Q2 2016, opening 15 new positions and adding to 9 existing holdings. Its largest new stake was Alexion Pharmaceuticals: 141,454 shares worth $16.5M.

By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 25% a quarter earlier, followed by Materials and Communication Services.

On the sell side, the largest reduction was T-Mobile US, an estimated $40.9M trimmed.

  • Exane Asset Management's largest Q2 2016 buy was Alexion Pharmaceuticals: 141,454 shares worth $16.5M.
  • Exane Asset Management added most to Gilead Sciences in Q2 2016, an estimated $16.9M increase.
  • Exane Asset Management's biggest Q2 2016 reduction was T-Mobile US, cutting an estimated $40.9M.
  • Exane Asset Management fully exited Celgene Corp in Q2 2016, selling an estimated $10.3M.
  • Exane Asset Management's ten largest holdings make up 62% of its $258M portfolio in Q2 2016.
  • Exane Asset Management opened 15 new positions and closed 8 in Q2 2016.
  • Exane Asset Management's portfolio value rose 34% quarter-over-quarter to $258M.

Based on Exane Asset Management's 13F filing for Q2 2016, filed 4 Aug 2016.